New Jersey’s Christie Being Treated in Hospital for Asthma – BusinessWeek


ABC News

New Jersey's Christie Being Treated in Hospital for Asthma
BusinessWeek
July 28 (Bloomberg) — New Jersey Governor Chris Christie is being treated in a hospital for asthma after he had difficulty breathing and should be released later today, according to his office. Christie, 48, an asthmatic who uses an
Chris Christie: Does he have the look of a president?Los Angeles Times
Test results normal for hospitalized NJ gov.The Associated Press
Gov. Christie said to be feeling OK; tests confirm asthma attackMyCentralJersey.com
Wall Street Journal (blog) –Christian Post –Bloomberg
all 703 news articles »

View full post on asthma – Google News

Goldman Sachs downgrades Glaxo to “sell” – BusinessWeek

Goldman Sachs downgrades Glaxo to "sell"
BusinessWeek
A Goldman Sacks analyst says GlaxoSmithKline's stock is overvalued as the British drugmaker prepares to face lower sales of its best-selling product, the asthma inhaler Advair. Goldman analyst Mark Beards notes the London-based drugmaker's shares have
Search Stocks To Watch TodayBarron’s (blog)
Goldman Sachs downgrades Glaxo to "sell"Forbes

all 7 news articles »

View full post on asthma – Google News

Study Ties Asthma to Higher Odds for Diabetes, Heart Disease – BusinessWeek


ModernMedicine

Study Ties Asthma to Higher Odds for Diabetes, Heart Disease
BusinessWeek
SUNDAY, March 20 (HealthDay News) — People with asthma may have a higher risk of developing diabetes and heart disease, according to a new study that looked at the relationship between asthma and four other inflammatory conditions.
Asthma May Raise Risk of Diabetes, Heart DiseaseWebMD
AAAAI: Asthma Tied to Higher Risk of Certain DiseasesDoctors Lounge
AAAAI: Asthma Patients More Likely to Have DiabetesMedPage Today
Pediatric SuperSite –AccentedTouch –CalorieLab Calorie Counter News
all 28 news articles »

View full post on asthma – Google News

Moms’ Use of ‘the Pill’ Won’t Raise Kids’ Asthma Risk: Study – BusinessWeek


ModernMedicine

Moms' Use of 'the Pill' Won't Raise Kids' Asthma Risk: Study
BusinessWeek
Some studies have suggested that a mother's use of birth control pills may increase the risk of asthma in children, but the data is limited and inconclusive, said the authors of the new study. The researchers examined the link between the type of birth
AAAAI: Combined OCPs Not Tied to Respiratory IssuesDoctors Lounge

all 10 news articles »

View full post on asthma – Google News

Firstborn Kids Seem to Have More Food Allergies, Hay Fever – BusinessWeek


TheMedGuru

Firstborn Kids Seem to Have More Food Allergies, Hay Fever
BusinessWeek
Japanese researchers surveyed parents of more than 13000 children aged 7 to 15 and found that a child's birth order did not seem to affect the prevalence of asthma or eczema. However, firstborn children were more likely to have hay fever,
Moms' Use of 'the Pill' Won't Raise Kids' Asthma Risk: StudyU.S. News & World Report
Firstborn Children More Likely To Develop Food Allergies, Study SaysABC News
AAAAI: Asthma Tracks Childhood ObesityMedPage Today
WHTC –msnbc.com –Pediatric SuperSite
all 94 news articles »

View full post on asthma – Google News

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study – BusinessWeek


LiveScience.com

Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study
BusinessWeek
WEDNESDAY, March 16 (HealthDay News) — The injectable medication Xolair reduced asthma symptoms in inner city children with the respiratory condition, and almost eliminated seasonal peaks in asthma attacks, new research shows.
Study Finds Adult Asthma Drug Dramatically Reduces Seasonal Attacks in KidsMyFox Washington DC
Asthma Worse In Children, Novartis' Xolair RecommendedMedical News Today
New study finds ways to help curb asthma among urban childrenSuperior Telegram
Sify –Clinical Advisor –msnbc.com
all 79 news articles »

View full post on asthma – Google News

Astra ends production of asthma inhaler – BusinessWeek

Astra ends production of asthma inhaler
BusinessWeek
AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma,
Astra pulls asthma product, hitting SkyePharmaReuters
AstraZeneca withdraws asthma drugManchester Evening News
AZ withdraws asthma drug, bad news for SkyePharmaPharma Times
InPharm –Telegraph.co.uk –In-PharmaTechnologist.com
all 51 news articles »

View full post on asthma – Google News